New Technologies to Increase Drug Candidate Survivability
	Strategic Research Institute , Philadelphia, PA September 11-12, 2000
	Solution for the Newest Discovery & Developement Bottleneck New Predictive ADME & Toxicology Techniques to Select the Best Development Candidates Organized Into FIVE sections: 1. Emerging Technologies in ADME & Predictive Toxicology 2. In Silico Techniques for ADME 3. Novel Advances in Informatics 4. In Vitro Screening 5. Modeling and Computational Approaches to ADME
	Organized by:	Strategic Research Institute
	Invited Speakers:	Featuring Big Pharma: -AstraZeneca Pharmaceuticals -Aventis Pharmaceuticals -Dupont Pharmaceuticals -Eli Lilly & Company -Glaxo Wellcome, Inc. -Merck & Company -Pfizer Central Research -Parke-Davis Research -Pharmacia Corporation -Schering-Plough Corporation -Wyeth Ayerst Research Also Featuring: -Arqule, Inc. -In Vitro Technologies -Quintiles, Inc. -Curagen Corporation -Trega Biosciences -Cerep, Inc. -Cyprotex, Inc. -BASF-LYNX Bioscience AG -Michigan State University
	Deadline for Abstracts:	N/A
	Registration:	Contact Customer Service at 800-599-4950, ext. 232 (outside USA 212-967-0095, ext. 232) email: info@srinstitute.com
	Email for Requests and Registration:	gpascual@srinstitute.com
	Posted by: Glenn A. Pascual   Host: mail.srinstitute.com date: July 10, 2000 17:43:36 Generated by meetings and positions 2.0 by Kai Garlipp Logo and Logo Images by Art for BioMed / Syrinx GmbH - Frankfurt / Germany. 4.1 (c) 1995-99 HUM-MOLGEN. All rights reserved. Liability and Copyright.